New insights about hematopoietic stem cell transplantation in adrenoleukodystrophy

Archives of Neurology

Volumn 64, Issue 5, 2007, Pages 631-632

  Moser, Hugo W ^b   Mahmood, Asif ^a  

^a KENNEDY KRIEGER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT;

ADRENAL GLAND; ADRENOLEUKODYSTROPHY; CHILDHOOD DISEASE; CYTOTOXIC T LYMPHOCYTE; EDITORIAL; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NERVOUS SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TREATMENT OUTCOME; X CHROMOSOME LINKED DISORDER;

ADRENOLEUKODYSTROPHY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS;

EID: 34249074281     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.64.5.631     Document Type: Editorial

References (14)

1. Aubourg P, Blanche S, Jambaque I, et al. Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation. N Engl J Med. 1990;322:1860-1866.
2. Shapiro E, Krivit W, Lockman L, et al. Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy. Lancet. 2000;356:713-718.
3. Peters C, Charnas LR, Tan Y, et al. Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood. 2004;104:881-888.
4. Loes DJ, Hite S, Moser H, et al. Adrenoleukodystrophy: a scoring method for brain MR observations. AJNR Am J Neuroradiol. 1994;15:1761-1766.
5. Mahmood A, Dubey P, Raymond GV, Moser HW. Evaluating survival in nontransplanted boys with the cerebral phenotype of X-linked adrenoleukodystrophy. Ann Neurol. 2005;58(suppl 9):52a.
6. Ito M, Blumberg BM, Mock DJ, et al. Potential environmental and host participants in the early white matter lesion of adreno-leukodystrophy: morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid antigen presentation. J Neuropathol Exp Neurol. 2001;60:1004-1019.
7. Walkley SU, Thrall MA, Dobrenis K, et al. Bone marrow transplantation corrects the enzyme defect in neurons of the central nervous system in a lysosomal storage disease. Proc Natl Acad Sci U S A. 1994;91:2970-2974.
8. Yamada T, Ohyagi Y, Shinnoh N, et al. Therapeutic effects of normal cells on ABCD1 deficient cells in vitro and hematopoietic cell transplantation in the X-ALD mouse model. J Neurol Sci. 2004;218:91-97.
9. Unger ER, Sung JH, Manivel JC, Chenggis ML, Blazar BR, Krivit W. Male donor-derived cells in the brains of female sex-mismatched bone marrow transplant recipients: a Y-chromosome specific in situ hybridization study. J Neuropathol Exp Neurol. 1993;52:460-470.
10. Hickey WF, Vass K, Lassmann H. Bone marrow-derived elements in the central nervous system: an immunohistochemical and ultrastructural survey of rat chimeras. J Neuropathol Exp Neurol. 1992;51:246-256.
11. Powers JM, Pei Z, Heinzer AK, et al. Adreno-leukodystrophy: oxidative stress of mice and men. J Neuropathol Exp Neurol. 2005;64:1067-1079.
12. Nowaczyk MJ, Saunders EF, Tein I, Blaser SI, Clarke JT. Immunoablation does not delay the neurologic progression of X-linked adrenoleukodystrophy. J Pediatr. 1997;131:453-455.
13. Korenke GC, Christen HJ, Kruse B, Hunneman DH, Hanefeld F. Progression of X-linked adrenoleukodystrophy under interferon-beta therapy. J Inherit Metab Dis. 1997;20:59-66.
14. Schönberger S, Roerig P, Schneider DT, Reifenberger G, Göbel U, Gärtner J. Genotype and protein expression after bone marrow transplantation for adrenoleukodystrophy. Arch Neurol. 2007;64:651-657.